RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced an upcoming conference call and webinar to highlight ...

Insiders have been showing their love for these four biotech stocks, and one tech stock, lately with huge share purchases.

Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.

Stocks Leading in March. In this article, we are going to take a look at where Mineralys Therapeutics, Inc. (NASDAQ:MLYS) ...

Find PECO on LinkedIn at https://www.linkedin.com/company/phillipsedison&company ...

Lorundrostat demonstrated strong efficacy and safety in the pivotal Phase 3 Launch-HTN and Phase 2 Advance-HTN trials. These ...

We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities acted as joint book-running managers for the offering. LifeSci Capital acted as lead manager and H.C.

Mineralys Therapeutics (MLYS) announced that data from the Phase 2 Advance-HTN trial evaluating the efficacy and safety of lorundrostat for the ...

AlphaQuest LLC boosted its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) by 2,637.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 15,222 shares of ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...